<SEC-DOCUMENT>0001193125-26-057168.txt : 20260218
<SEC-HEADER>0001193125-26-057168.hdr.sgml : 20260218
<ACCEPTANCE-DATETIME>20260218163103
ACCESSION NUMBER:		0001193125-26-057168
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260213
FILED AS OF DATE:		20260218
DATE AS OF CHANGE:		20260218

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Moran Sean F.
		CENTRAL INDEX KEY:			0001451495
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37348
		FILM NUMBER:		26648943

	MAIL ADDRESS:	
		STREET 1:		C/O CORBUS PHARMACEUTICALS HOLDINGS, INC
		STREET 2:		500 RIVER RIDGE DRIVE
		CITY:			NORWOOD
		STATE:			MA
		ZIP:			02062

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Corbus Pharmaceuticals Holdings, Inc.
		CENTRAL INDEX KEY:			0001595097
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				464348039
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		500 RIVER RIDGE DRIVE
		CITY:			NORWOOD
		STATE:			MA
		ZIP:			02062
		BUSINESS PHONE:		617-963-0103

	MAIL ADDRESS:	
		STREET 1:		500 RIVER RIDGE DRIVE
		CITY:			NORWOOD
		STATE:			MA
		ZIP:			02062

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAV Acquisition Corp
		DATE OF NAME CHANGE:	20131220
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2026-02-13</periodOfReport>

    <issuer>
        <issuerCik>0001595097</issuerCik>
        <issuerName>Corbus Pharmaceuticals Holdings, Inc.</issuerName>
        <issuerTradingSymbol>CRBP</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001451495</rptOwnerCik>
            <rptOwnerName>Moran Sean F.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O CORBUS PHARMACEUTICALS HOLDINGS, INC</rptOwnerStreet1>
            <rptOwnerStreet2>500 RIVER RIDGE DRIVE</rptOwnerStreet2>
            <rptOwnerCity>NORWOOD</rptOwnerCity>
            <rptOwnerState>MA</rptOwnerState>
            <rptOwnerZipCode>02062</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>false</isDirector>
            <isOfficer>true</isOfficer>
            <isTenPercentOwner>false</isTenPercentOwner>
            <isOther>false</isOther>
            <officerTitle>Chief Financial Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>true</aff10b5One>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock, par value $0.0001 per share</value>
            </securityTitle>
            <transactionDate>
                <value>2026-02-13</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>false</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>4701</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>7.7830</value>
                    <footnoteId id="F2"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>96694</value>
                    <footnoteId id="F3"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025 and the sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (&quot;RSUs&quot;). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a &quot;sell to cover&quot; transaction and does not represent a discretionary transaction by the Reporting Person.</footnote>
        <footnote id="F2">The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.58 to $7.96. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.</footnote>
        <footnote id="F3">This amount includes 68,795 unvested RSUs subject to each grant's vesting schedule as previously reported.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Sean Moran</signatureName>
        <signatureDate>2026-02-18</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
